Status:
COMPLETED
Increasing the Uptake of Influenza and Pneumococcal Vaccines Among High-Risk Adult Patients Through GP Clinics
Lead Sponsor:
Tan Tock Seng Hospital
Collaborating Sponsors:
Frontier Healthcare Group
OneCare Medical Group
Conditions:
Immunization Programs
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Pneumonia and influenza are among the top causes of hospitalisation and death in the elderly. While vaccinations are recommended against these diseases, a large proportion of elderly in the community ...
Detailed Description
Influenza and pneumococcal disease contribute considerably to hospitalisation and mortality in the elderly. While recommended vaccines can reduce disease burden, vaccine uptake remains very low in Sin...
Eligibility Criteria
Inclusion
- Patients seen at GP clinics involved in our study AND
- Aged 65 years and above, with or without chronic disease
Exclusion
- Patients not seen at GP clinics involved in our study
- Patients aged below 65 years old
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2018
Estimated Enrollment :
8837 Patients enrolled
Trial Details
Trial ID
NCT03445117
Start Date
November 1 2017
End Date
July 31 2018
Last Update
July 5 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Frontier Healthcare Group
Singapore, Singapore, 400305
2
OneCare Medical Group
Singapore, Singapore, 609966